SCHEMBL17667995

SCHEMBL17667995

CC(CC(Cc1ccc(-c2ccccc2)cc1)NC(=O)c1noc(=O)[nH]1)C(=O)O

nearest known ligand 0.66

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 12/20 0.66
▸ MMEL1 Q495T6 9/20 0.61
▸ ACE P12821 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10198029 1.00 MME (0.66) MMEMMEL1ACE
SCHEMBL18672751 1.00 MME (0.66) MMEMMEL1ACE
SCHEMBL18672661 0.91 MME (0.69) MMEMMEL1ACE
SCHEMBL2705850 0.91 MME (0.69) MMEMMEL1ACE
SCHEMBL2706754 0.91 MME (0.69) MMEMMEL1ACE
SCHEMBL9941015 0.90 MME (0.71) MME
SCHEMBL9929986 0.90 MME (0.71) MME
SCHEMBL12317404 0.89 MME (0.53) MMEMMEL1ACE
SCHEMBL18672734 0.89 MME (0.53) MMEMMEL1ACE
SCHEMBL12975394 0.86 MMEL1 (0.58) MMEMMEL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3048100-A1 SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS Novartis AG (CH) 2016-07-27 — — EP disclosed
EP-2435402-B1 SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS NOVARTIS AG (CH) 2016-04-13 — — EP disclosed
Send feedback